Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71,833,789
-
Total 13F shares
-
49,748,691
-
Share change
-
+7,116,918
-
Total reported value
-
$1,666,552,132
-
Put/Call ratio
-
45%
-
Price per share
-
$33.50
-
Number of holders
-
143
-
Value change
-
+$240,845,778
-
Number of buys
-
84
-
Number of sells
-
59
Institutional Holders of Ventyx Biosciences, Inc. - Common Stock (VTYX) as of Q1 2023
As of 31 Mar 2023,
Ventyx Biosciences, Inc. - Common Stock (VTYX) was held by
143 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,748,691 shares.
The largest 10 holders included
FMR LLC, CITADEL ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, Capital International Investors, venBio Partners LLC, BlackRock Inc., Avidity Partners Management LP, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, and RTW INVESTMENTS, LP.
This page lists
143
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.